Insight Event for Retail Investors
N4 Pharma to host investor insight event on 14 July 2025 featuring CEO and senior leadership presentations.
Select text to share a quote on X · sign in to keep highlights & notes in your THAT notes
N4 Pharma plc (AIM: N4P), the UK biotech developing Nuvec®, its proprietary gene delivery system to enable advanced therapies for cancer and other diseases, is pleased to announce that it will host an Investor Insight Event for retail investors on Monday, 14 July 2025 at the Royal College of Surgeons, 38-43 Lincoln's Inn Fields, London, WC2A 3PE from 10.00 am until 12.00 pm.
During the event, Nigel Theobald, Chief Executive Officer, will provide a strategic update on the Company's ongoing development of Nuvec® as a delivery system for RNA therapeutics. He will be joined by members of the Senior Leadership Team, including:
- Mark Edbrooke, Head of Strategy, presenting on The RNA Therapeutics Revolution
- Dr Fiona McLaughlin, Head of Research and Development, presenting on Established Delivery Platforms and the Key Benefits of Nuvec®
The event will include a Q&A session, offering investors the opportunity to engage directly with the executive team. This will be followed by a networking lunch, where attendees can meet other members of the Board and senior management.
The event is free to attend and open to all existing and prospective shareholders.
To register for the event, please contact sarah@northstarcommunications.co.uk
A recording of the presentation will be made available on the Company's website following the event at: https://www.n4pharma.com/.
| N4 Pharma plc Nigel Theobald, CEO Luke Cairns, Executive Director Submit your questions directly to the management team via the N4 Pharma Investor Hub | Via N4 Pharma Investor Hub: investors.n4pharma.com https://investors.n4pharma.com/link/7PR55r |
| SP Angel Corporate Finance LLP Nominated Adviser and Joint Broker Matthew Johnson/Jen Clarke (Corporate Finance) Vadim Alexandre/Abigail Wayne/Rob Rees (Corporate Broking) | Tel: +44 (0)20 3470 0470 |
| Turner Pope Investments (TPI) Limited Joint Broker Andy Thacker James Pope | Tel: +44 (0)20 3657 0050 |
| Northstar Communications Limited Investor Relations Sarah Hollins | Tel: +44 (0)113 730 3896 |
About N4 Pharma
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.